4//SEC Filing
SPENCER DALE A 4
Accession 0001318310-06-000003
CIK 0001318310other
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:09 PM ET
Size
16.0 KB
Accession
0001318310-06-000003
Insider Transaction Report
Form 4
ev3 Inc.EVVV
SPENCER DALE A
Director
Transactions
- Award
Stock Option (right to buy)
2006-01-06+7,620→ 7,620 totalExercise: $12.58Exp: 2011-05-31→ Common stock (7,620 underlying) - Award
Stock Option (right to buy)
2006-01-06+1,905→ 1,905 totalExercise: $9.96Exp: 2012-05-30→ Common Stock (1,905 underlying) - Award
Stock option (right to buy)
2006-01-06+1,905→ 1,905 totalExercise: $6.47Exp: 2013-05-22→ Common Stock (1,905 underlying) - Award
Stock options (right to buy)
2006-01-06+1,905→ 1,905 totalExercise: $8.40Exp: 2015-05-25→ Common stock (1,905 underlying)
Footnotes (5)
- [F1]Reporting Person's stock options to purchase common stock in Micro Therapeutics, Inc. were exchanged for stock options to purchase common stock in the issuer in connection with the merger between Micro Therapeutics, Inc. and a wholly-owned subsidiary of the issuer (the "Merger'). On the effective date of the Merger, the closing price of Micro Therapeutics, Inc. common stock was $6.64 per share, and the closing price of ev3 Inc. common stock was $14.00 per share. The issuer's board of directors approved all issuances to Reporting Person that are subject of this report. Received in the Merger in exchange for an option to purchase 16,00 shares of Micro Therapeutics, Inc. common stock for $5.99 per share. Vesting schedule continued as originally set and issuer options are fully vested.
- [F2]Received in the Merger in exchange for an option to purchase 4000 shares of Micro Therapeutics, Inc. common stock for $4.74 per share. Vesting schedule continued as originally set and issuer options are fully vested.
- [F3]Received in the Merger in exchange for an option to purchase 4000 shares of Micro Therapeutics, Inc. common stock of $3.08 per share, which provided for vesting in the amount of 25% on May 22, 2003, with the remainder vesting in three equal annual installments thereafter. Vesting schedule continues as originally set.
- [F4]Received in the Merger in exchange for an option to purchase 4000 shares of Micro Therapeutics, Inc. common stock for $4.17 per share, which provided for vesting in the amount of 25% on May 20, 2004, with the remainder vesting in three equal annual installments thereafter. Vesting schedule continues as originally set.
- [F5]Received in the Merger in exchange for an option to purchase 4000 shares of Micro Therapeutics, Inc. common stock for $4.00 per share, which provided for vesting in the amount of 25% on May 26, 2005, with the remainder vesting in three equal annual installments thereafter. Vesting schedule continues as originally set.
Documents
Issuer
ev3 Inc.
CIK 0001318310
Entity typeother
Related Parties
1- filerCIK 0001215244
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:09 PM ET
- Size
- 16.0 KB